Search - tctmd.com

Displaying 901 - 920 of 1470

Sort: Relevancy | Date

News Industry News

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

October 26, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

News Conference News TCT 2015

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

October 13, 2015

News Conference News TCT 2015

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Todd Neale

October 13, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

News Industry News

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

October 12, 2015

News Conference News TCT 2015

Speakers Consider the Efficacy of Hemodynamic Support for Cardiogenic Shock After Acute MI

October 12, 2015

News Conference News TCT 2015

Despite Setbacks, Research Into Myocardial Salvage Continues

October 12, 2015

News Conference News TCT 2015

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

October 11, 2015

News Conference News TCT 2015

Leadership at Forefront of Cath Lab Operations

Yael L. Maxwell

October 11, 2015

News Conference News TCT 2015

Cardioband Shows Benefits for Secondary Mitral Regurgitation

October 11, 2015

News Daily News

血运重建可能会令无法进行适当性评分的冠脉疾病患者受益

Todd Neale

October 08, 2015

News Daily News

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

Todd Neale

October 08, 2015

News Daily News

La Revascularización Podría Beneficiar a Pacientes con EAC Estable Con Puntuaciones Inclasificables de Conveniencia

Todd Neale

October 08, 2015

News Industry News

EBR Systems Receives European CE Mark Approval for World’s First Wireless Cardiac Pacing System for Heart Failure

October 06, 2015

News Daily News

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

October 01, 2015

News Daily News

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

October 01, 2015

News Daily News

En los Albores de la TAVR, No Hubo Más Mortalidad en Pacientes tratados en Centros No Participantes en Ensayos

October 01, 2015

Advertisement

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Companies With Innovative Technologies Compete in TCT Shark Tank

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

Speakers Consider the Efficacy of Hemodynamic Support for Cardiogenic Shock After Acute MI

Despite Setbacks, Research Into Myocardial Salvage Continues

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

Leadership at Forefront of Cath Lab Operations

Cardioband Shows Benefits for Secondary Mitral Regurgitation

血运重建可能会令无法进行适当性评分的冠脉疾病患者受益

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

La Revascularización Podría Beneficiar a Pacientes con EAC Estable Con Puntuaciones Inclasificables de Conveniencia

EBR Systems Receives European CE Mark Approval for World’s First Wireless Cardiac Pacing System for Heart Failure

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

En los Albores de la TAVR, No Hubo Más Mortalidad en Pacientes tratados en Centros No Participantes en Ensayos

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content